Mesoblast Limited: MESOBLAST PARTNERS WITH BLOOD AND MARROW TRANSPLANT CLINICAL TRIALS NETWORK (BMT CTN) ON PIVOTAL TRIAL IN ADULTS WITH SR-aGVHD

Press/Media

Period23 Nov 2023

Media coverage

1

Media coverage

  • TitleMesoblast Limited: MESOBLAST PARTNERS WITH BLOOD AND MARROW TRANSPLANT CLINICAL TRIALS NETWORK (BMT CTN) ON PIVOTAL TRIAL IN ADULTS WITH SR-aGVHD
    Media name/outletImpact Financial News
    Country/TerritoryUnited Kingdom
    Date23/11/23
    PersonsJohn Levine
View all 1
View less